公开(公告)号：EP3833371A1

公开(公告)日：2021-06-16

申请号：EP19773914.7

申请日：2019-08-07

申请人： Mehta, Raman

发明人： Mehta, Raman

IPC分类号： A61K36/67 ,  A61K36/9068 ,  A61K36/324 ,  A61K36/37 ,  A61K36/28 ,  A61P19/02 ,  A61P23/00 ,  A61P43/00

公开(公告)号：EP3607959A1

公开(公告)日：2020-02-12

申请号：EP18188413.1

申请日：2018-08-10

申请人： Mehta, Raman

发明人： Mehta, Raman

IPC分类号： A61K36/67 ,  A61K36/9068 ,  A61K36/324 ,  A61K36/37 ,  A61K36/28 ,  A61P19/02 ,  A61P23/00 ,  A61P43/00

摘要： The present invention concerns with new compositions containing lipophilic extracts of Piper nigrum, Zingiber officinale, Boswellia serrata and other plants used as adjuvant, prepared using as a solvent fluorinated hydrocarbons fluids in subcritical conditions. The compositions properly formulated are useful for topical and systemic treatment of pain and inflammation. The formulations are also active in muscle spasticity and neuropathic pains.
The formulations according to the invention, exerting a powerful synergistic effect, are particularly useful in the treatment of osteoarthrosis, osteoarthritis and arthritis psoriatic pain alone or in combination with specific drugs.
By topical application the formulation in form of creams, lotions or massage oils are indicated to reduce superficial and deep pain, edema and irritation of any origins.

公开(公告)号：EP2684567B1

公开(公告)日：2018-04-25

申请号：EP12758054.6

申请日：2012-03-09

申请人： Castañeda Miranda, José Arturo

发明人： Castañeda Miranda, José Arturo

IPC分类号： A61K36/515 ,  A61K36/37 ,  A61P9/10

CPC分类号： A61K36/515 ,  A61K36/37 ,  A61K2300/00

摘要： Herbal MDR for the prevention and treatment of atherosclerosis which includes a summary of the genus Gentiana and a summary of the genus Hippocratea, in particular, gentiana lutea and hippocratea excelsa. Comes as a solid, preferably capsules. Herbal composition is obtained by selecting Rhizome and root of Gentiana luteablending by centrifugation, and separating the supernatant which mingles with the alcoholic extract of Hippocratea excelsa. Applies in the prevention and treatment of atherosclerosis, as well as in atherosclerotic Occlusive disease complications such as blockage of coronary arteries and arteries that supply the heart.

公开(公告)号：EP3199170A3

公开(公告)日：2017-10-25

申请号：EP17153019.9

申请日：2017-01-25

申请人： Fujifilm Corporation

发明人： Oda, Yuriko ,  Ueda, Fumitaka

IPC分类号： A61K36/37 ,  A61P1/00

CPC分类号： A61K36/37 ,  A61K2236/15 ,  A61K2236/331 ,  A61K2236/51

摘要： An object of the present invention is to provide an agent for suppressing the number of intestinal bacteria, which is capable of suppressing the number of particular intestinal bacteria associated with a disease, and a food and pharmaceutical product containing the agent for suppressing the number of intestinal bacteria. The present invention provides an agent for suppressing the number of intestinal bacteria, which contains an extract and/or crushed product of a plant of the genus Salacia, wherein the intestinal bacterium is at least one which is selected from the group consisting of the families Lachnospiraceae, Ruminococcaceae, Fusobacteriaceae, and Desulfovibrionaceae.

摘要翻译： 本发明的目的在于提供能够抑制与疾病相关的特定的肠内细菌的数量的用于抑制肠内细菌的数量的药剂以及含有用于抑制肠内细菌的数量的药剂的食品和药品 菌。 本发明提供一种抑制肠内细菌数的药剂，其含有五层龙属植物的提取物和/或粉碎物，其中，所述肠细菌为选自纤毛虫科（Lachnospiraceae） ，Ruminococcaceae，Fusobacteriaceae和Desulfovibrionaceae。

公开(公告)号：EP3199170A1

公开(公告)日：2017-08-02

申请号：EP17153019.9

申请日：2017-01-25

申请人： Fujifilm Corporation

发明人： Oda, Yuriko ,  Ueda, Fumitaka

IPC分类号： A61K36/37 ,  A61P1/00

CPC分类号： A61K36/37 ,  A61K2236/15 ,  A61K2236/331 ,  A61K2236/51

摘要： An object of the present invention is to provide an agent for suppressing the number of intestinal bacteria, which is capable of suppressing the number of particular intestinal bacteria associated with a disease, and a food and pharmaceutical product containing the agent for suppressing the number of intestinal bacteria. The present invention provides an agent for suppressing the number of intestinal bacteria, which contains an extract and/or crushed product of a plant of the genus Salacia, wherein the intestinal bacterium is at least one which is selected from the group consisting of the families Lachnospiraceae, Ruminococcaceae, Fusobacteriaceae, and Desulfovibrionaceae.

公开(公告)号：EP2680870A4

公开(公告)日：2015-09-02

申请号：EP12752724

申请日：2012-03-01

申请人： PHYTOMEDICS CORP INC

发明人： PAFFENDORF GEORGE ,  CIMARUSTI CHRISTOPHER

IPC分类号： A61K36/37 ,  A23L19/00

CPC分类号： A61K36/37 ,  A61K2236/333

摘要： Products derived from the Tripterygium wilfordii Hook F (TwHF) plant in the form of extracts are provided that are useful in preventing, treating, or ameliorating a symptom of an inflammatory disorder or an immune disorder, such as an auto-immune disease. Also provided are methods of freeze-drying a TwHF root and/or root portion, methods of debarking a freeze-dried TwHF root and/or root portion, methods of preparing and/or refining extracts in freely flowable solid form from freeze-dried debarked TwHF roots and/or root portions, and methods of using freely flowable solid extracts of TwHF in preventing, treating or ameliorating a symptom of an inflammatory disorder and/or an immune disorder.

公开(公告)号：EP2684567A4

公开(公告)日：2014-09-24

申请号：EP12758054

申请日：2012-03-09

申请人： CASTAÑEDA MIRANDA JOSÉ ARTURO

发明人： CASTAÑEDA MIRANDA JOSÉ ARTURO

IPC分类号： A61K36/515 ,  A61K36/37 ,  A61P9/10

CPC分类号： A61K36/515 ,  A61K36/37 ,  A61K2300/00

摘要： Herbal MDR for the prevention and treatment of atherosclerosis which includes a summary of the genus Gentiana and a summary of the genus Hippocratea, in particular, gentiana lutea and hippocratea excelsa. Comes as a solid, preferably capsules. Herbal composition is obtained by selecting Rhizome and root of Gentiana luteablending by centrifugation, and separating the supernatant which mingles with the alcoholic extract of Hippocratea excelsa. Applies in the prevention and treatment of atherosclerosis, as well as in atherosclerotic Occlusive disease complications such as blockage of coronary arteries and arteries that supply the heart.

摘要翻译： 用于预防和治疗动脉粥样硬化的草药MDR，其包括龙胆草属的概要和Hippocratea属的总结，特别是黄连和海马。 作为固体，优选胶囊。 通过离心分离提取龙胆草的根茎和根，并分离出与Hippocratea的酒精提取物混合的上清液，得到草药成分。 适用于预防和治疗动脉粥样硬化，以及动脉粥样硬化性闭塞性疾病并发症，如阻塞冠状动脉和供应心脏的动脉。

公开(公告)号：EP2540316A4

公开(公告)日：2013-08-21

申请号：EP10846634

申请日：2010-12-03

申请人： FUJIFILM CORP

发明人： ODA YURIKO ,  UEDA FUMITAKA

IPC分类号： A61K45/06 ,  A23L1/30 ,  A61K36/18 ,  A61K36/37 ,  A61K36/48 ,  A61K36/60 ,  A61K38/16 ,  A61K38/39 ,  A61P3/04

CPC分类号： A61K38/02 ,  A23L33/105 ,  A23L33/18 ,  A23V2002/00 ,  A61K35/60 ,  A61K36/18 ,  A61K36/185 ,  A61K36/37 ,  A61K36/48 ,  A61K36/605 ,  A61K38/168 ,  A61K38/39 ,  A61K45/06 ,  A61K2300/00 ,  A23V2250/5488 ,  A23V2250/2042 ,  A23V2200/332

摘要： The present invention provides a body weight gain suppressing composition including an ±-glucosidase activity inhibitor component, preferably a component derived from at least one plant selected from the group consisting of Salacia genus plants, touchi and mulberry, and a lipid synthesis inhibitor component, preferably, at least one selected from the group consisting of soybean peptide, marine animal peptide, and sesame lignin, and also provides a food product including the composition.

公开(公告)号：EP2540315A4

公开(公告)日：2013-08-21

申请号：EP11747344

申请日：2011-02-22

申请人： FUJIFILM CORP

发明人： ODA YURIKO ,  UEDA FUMITAKA

IPC分类号： A61K45/06 ,  A61K36/27 ,  A61K36/37 ,  A61K36/60 ,  A61P1/16 ,  A61P43/00

CPC分类号： A61K45/06 ,  A61K36/37 ,  A61K2300/00

公开(公告)号：EP2326338A2

公开(公告)日：2011-06-01

申请号：EP09741450.2

申请日：2009-09-17

申请人： Innoveda Biological Solutions (P) Ltd.

发明人： KRISHNAN, G., Geetha

IPC分类号： A61K36/47 ,  A61K36/23 ,  A61K36/89 ,  A61K36/37 ,  A61K36/48 ,  A61K36/906 ,  A61K36/29 ,  A61K36/22 ,  A61K36/72 ,  A61K36/59 ,  A61K36/899

CPC分类号： A61K36/00 ,  A61K2300/00

摘要： An herbal formulation for prevention and treatment of Diabetes and associated complications comprising extracts from selected Indian medicinal herbs Emblica officinalis Gaertn. of the Euphorbiaceae Family, Species of herbs of the Genus Salacia of the of the Celastraceae family, Species Strychnos potatorum L. f. of the Strychnaceae family, Species Vetiveria zizanioides (L.) Nash of the Poaceae family, Species Curcuma longa L. of the Zingiberaceae family, Species of herbs of the Genus Aerva of the Amaranthaceae family, Species of herbs of the Genus Biophytum of the Oxalidaceae family, Species of herbs of the Genus Syzygium of the Myrtaceae family, Species Mangifera indica L. of the Anacardiaceae family, Species of herbs of the Genus Cyclea and/or the Genus Cissampelos of the Menispermaceae family, Species of herbs of the Genus Embelia of the Myrsinaceae family, Species of herbs of the Genus Cyperus of the Cyperaceae family, Species Terminalia chebula (Gaertn.) Retz. of the Combretaceae family, Species Centella asiatica (L.) Urban of the Apiaceae family and/or the Species Strychnos nux-vomica L. of the Strychnaceae family and/or the Species Butea frondosa Koen. ex Roxb. of the Papilionaceae family and/or the Species Acacia catechu (L.f.) WiIId. of the Mimosaceae family, Species Coscinium fenestratum (Gaertn.) Colebr. of the Menispermaceae family and/or the Species of herbs of the Genus Berberis of the Berberidaceae family, and species of herbs of the Genus Zizyphus of the Rhamnaceae family. The invention has associate formulations for different diabetes related complications, which are individually useful in clinical requirements such as improving renal health and preventing renal diseases, preventing diabetic retinopathy and prevention and treatment for oxidative damage to heart and blood vessels. The invention is versatile and can be processed into extracts / concentrates and further pharmacologically modified to tablets or capsules or granules or syrups or herbal health drink or inhalable herbal medicinal preparations or ocular preparations or transdermal absorbable preparations such as ointments / gels or injectable medicine.